nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.509	0.622	CbGaD
Testosterone Propionate—AR—polycystic ovary syndrome	0.31	0.378	CbGaD
Testosterone Propionate—CYP17A1—ovarian follicle—polycystic ovary syndrome	0.0242	0.362	CbGeAlD
Testosterone Propionate—UGT1A1—urine—polycystic ovary syndrome	0.00925	0.138	CbGeAlD
Testosterone Propionate—CYP17A1—adrenal cortex—polycystic ovary syndrome	0.00268	0.0401	CbGeAlD
Testosterone Propionate—COMT—adrenal cortex—polycystic ovary syndrome	0.00196	0.0293	CbGeAlD
Testosterone Propionate—CYP17A1—adrenal gland—polycystic ovary syndrome	0.00193	0.0289	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.00186	0.0177	CbGpPWpGaD
Testosterone Propionate—CYP17A1—female gonad—polycystic ovary syndrome	0.0018	0.027	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.00177	0.0169	CbGpPWpGaD
Testosterone Propionate—COMT—endometrium—polycystic ovary syndrome	0.00175	0.0262	CbGeAlD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—SHBG—polycystic ovary syndrome	0.00173	0.0165	CbGpPWpGaD
Testosterone Propionate—CYP17A1—endocrine gland—polycystic ovary syndrome	0.00168	0.0251	CbGeAlD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—TH—polycystic ovary syndrome	0.00167	0.016	CbGpPWpGaD
Testosterone Propionate—COMT—uterus—polycystic ovary syndrome	0.00161	0.0241	CbGeAlD
Testosterone Propionate—COMT—pituitary gland—polycystic ovary syndrome	0.00158	0.0237	CbGeAlD
Testosterone Propionate—COMT—adipose tissue—polycystic ovary syndrome	0.00158	0.0236	CbGeAlD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—TMF1—polycystic ovary syndrome	0.00156	0.0149	CbGpPWpGaD
Testosterone Propionate—UGT1A1—endocrine gland—polycystic ovary syndrome	0.00153	0.0229	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.00151	0.0144	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Glucocorticoid biosynthesis—POMC—polycystic ovary syndrome	0.00146	0.0139	CbGpPWpGaD
Testosterone Propionate—AR—adrenal cortex—polycystic ovary syndrome	0.00143	0.0214	CbGeAlD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP11A1—polycystic ovary syndrome	0.00141	0.0135	CbGpPWpGaD
Testosterone Propionate—COMT—adrenal gland—polycystic ovary syndrome	0.00141	0.0211	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.00137	0.0131	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00134	0.0128	CbGpPWpGaD
Testosterone Propionate—COMT—female gonad—polycystic ovary syndrome	0.00132	0.0197	CbGeAlD
Testosterone Propionate—COMT—vagina—polycystic ovary syndrome	0.00131	0.0196	CbGeAlD
Testosterone Propionate—AR—endometrium—polycystic ovary syndrome	0.00128	0.0191	CbGeAlD
Testosterone Propionate—COMT—endocrine gland—polycystic ovary syndrome	0.00123	0.0183	CbGeAlD
Testosterone Propionate—AR—uterus—polycystic ovary syndrome	0.00118	0.0176	CbGeAlD
Testosterone Propionate—AR—pituitary gland—polycystic ovary syndrome	0.00116	0.0173	CbGeAlD
Testosterone Propionate—AR—adipose tissue—polycystic ovary syndrome	0.00115	0.0173	CbGeAlD
Testosterone Propionate—CYP17A1—Androgen biosynthesis—POMC—polycystic ovary syndrome	0.00113	0.0108	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00107	0.0102	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.00106	0.0101	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP19A1—polycystic ovary syndrome	0.00104	0.00993	CbGpPWpGaD
Testosterone Propionate—AR—adrenal gland—polycystic ovary syndrome	0.00104	0.0155	CbGeAlD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.000994	0.00948	CbGpPWpGaD
Testosterone Propionate—AR—female gonad—polycystic ovary syndrome	0.000965	0.0144	CbGeAlD
Testosterone Propionate—AR—vagina—polycystic ovary syndrome	0.000959	0.0143	CbGeAlD
Testosterone Propionate—AR—endocrine gland—polycystic ovary syndrome	0.000898	0.0134	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.00078	0.00744	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000767	0.00732	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000657	0.00627	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000648	0.00619	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000643	0.00613	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000639	0.00609	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Endogenous sterols—POMC—polycystic ovary syndrome	0.000626	0.00597	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000615	0.00587	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000614	0.00585	CbGpPWpGaD
Testosterone Propionate—Finasteride—SRD5A1—polycystic ovary syndrome	0.000593	0.0639	CrCbGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000589	0.00562	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00057	0.00544	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000533	0.00508	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CAMK2D—polycystic ovary syndrome	0.000531	0.00507	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000485	0.00463	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000483	0.00461	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000477	0.00455	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000469	0.00447	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000461	0.0044	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—SRD5A1—polycystic ovary syndrome	0.000397	0.0429	CrCbGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000392	0.00374	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00039	0.00372	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.000386	0.00368	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000385	0.00367	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000385	0.00367	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000382	0.0412	CrCbGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000366	0.00349	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000366	0.00349	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000357	0.00341	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NCOR1—polycystic ovary syndrome	0.000352	0.00336	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000342	0.00327	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000342	0.00326	CbGpPWpGaD
Testosterone Propionate—Dydrogesterone—PGR—polycystic ovary syndrome	0.000336	0.0362	CrCbGaD
Testosterone Propionate—COMT—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000334	0.00318	CbGpPWpGaD
Testosterone Propionate—Stanozolol—AR—polycystic ovary syndrome	0.000332	0.0358	CrCbGaD
Testosterone Propionate—COMT—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000329	0.00314	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000319	0.00305	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000316	0.00301	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000315	0.00301	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.00031	0.00296	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000305	0.00291	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000303	0.00289	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000301	0.00288	CbGpPWpGaD
Testosterone Propionate—Oxandrolone—AR—polycystic ovary syndrome	0.000299	0.0322	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000299	0.00285	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—NR3C1—polycystic ovary syndrome	0.000296	0.00282	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000295	0.00282	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—polycystic ovary syndrome	0.000293	0.00279	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000291	0.00278	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000291	0.00277	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000283	0.0027	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000279	0.00266	CbGpPWpGaD
Testosterone Propionate—Ethynodiol—PGR—polycystic ovary syndrome	0.000277	0.0298	CrCbGaD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000275	0.00263	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000275	0.00262	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000273	0.0026	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000271	0.00258	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000264	0.00251	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—INS—polycystic ovary syndrome	0.000261	0.00249	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000247	0.00236	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000243	0.00232	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00024	0.00229	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00024	0.00229	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000236	0.00225	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000236	0.00225	CbGpPWpGaD
Testosterone Propionate—Norgestimate—PGR—polycystic ovary syndrome	0.000235	0.0254	CrCbGaD
Testosterone Propionate—Nandrolone phenpropionate—AR—polycystic ovary syndrome	0.000234	0.0252	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000228	0.00217	CbGpPWpGaD
Testosterone Propionate—Drostanolone—SHBG—polycystic ovary syndrome	0.000227	0.0245	CrCbGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000219	0.00209	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000217	0.00207	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000214	0.00205	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000214	0.00204	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000212	0.0228	CrCbGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—NCOR1—polycystic ovary syndrome	0.000211	0.00201	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000211	0.00201	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000208	0.00199	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000205	0.00196	CbGpPWpGaD
Testosterone Propionate—Megestrol acetate—PGR—polycystic ovary syndrome	0.000202	0.0218	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000201	0.00192	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000201	0.00191	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.0002	0.00191	CbGpPWpGaD
Testosterone Propionate—Drostanolone—AR—polycystic ovary syndrome	0.000199	0.0215	CrCbGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000197	0.00188	CbGpPWpGaD
Testosterone Propionate—Nandrolone phenpropionate—CYP19A1—polycystic ovary syndrome	0.000196	0.0211	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00019	0.00182	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000189	0.00181	CbGpPWpGaD
Testosterone Propionate—Testolactone—CYP19A1—polycystic ovary syndrome	0.000187	0.0201	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000182	0.00173	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.00018	0.00172	CbGpPWpGaD
Testosterone Propionate—Nandrolone decanoate—AR—polycystic ovary syndrome	0.000177	0.0191	CrCbGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000177	0.00169	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PGR—polycystic ovary syndrome	0.000176	0.019	CrCbGaD
Testosterone Propionate—AR—Gene Expression—ZNF430—polycystic ovary syndrome	0.000176	0.00168	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ZNF205—polycystic ovary syndrome	0.000176	0.00168	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000175	0.00167	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000175	0.00167	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000173	0.00165	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000173	0.00165	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000169	0.00161	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000168	0.0016	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—DLG4—polycystic ovary syndrome	0.000168	0.0016	CbGpPWpGaD
Testosterone Propionate—Drostanolone—CYP19A1—polycystic ovary syndrome	0.000167	0.018	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000167	0.00159	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000165	0.00158	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000165	0.00157	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000165	0.00157	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000163	0.00155	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000162	0.00155	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.000158	0.00151	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000154	0.00147	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NMNAT3—polycystic ovary syndrome	0.000154	0.00147	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ADARB1—polycystic ovary syndrome	0.00015	0.00143	CbGpPWpGaD
Testosterone Propionate—Nandrolone decanoate—CYP19A1—polycystic ovary syndrome	0.000148	0.016	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000148	0.00141	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000147	0.0014	CbGpPWpGaD
Testosterone Propionate—Drospirenone—AR—polycystic ovary syndrome	0.000145	0.0156	CrCbGaD
Testosterone Propionate—Levonorgestrel—PGR—polycystic ovary syndrome	0.000144	0.0155	CrCbGaD
Testosterone Propionate—COMT—Metabolism—LPCAT2—polycystic ovary syndrome	0.000141	0.00134	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SUOX—polycystic ovary syndrome	0.000141	0.00134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000141	0.00134	CbGpPWpGaD
Testosterone Propionate—Loteprednol—NR3C1—polycystic ovary syndrome	0.000138	0.0149	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000138	0.00131	CbGpPWpGaD
Testosterone Propionate—Fludrocortisone—AR—polycystic ovary syndrome	0.000136	0.0147	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—SUOX—polycystic ovary syndrome	0.000135	0.00129	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000135	0.00129	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000135	0.00129	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—SHBG—polycystic ovary syndrome	0.000135	0.0145	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000133	0.00127	CbGpPWpGaD
Testosterone Propionate—Danazol—PGR—polycystic ovary syndrome	0.000131	0.0141	CrCbGaD
Testosterone Propionate—COMT—Metabolism—ISYNA1—polycystic ovary syndrome	0.000131	0.00125	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—POMC—polycystic ovary syndrome	0.000131	0.00125	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00013	0.00124	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000128	0.00123	CbGpPWpGaD
Testosterone Propionate—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000128	0.0138	CrCbGaD
Testosterone Propionate—Medrysone—NR3C1—polycystic ovary syndrome	0.000127	0.0137	CrCbGaD
Testosterone Propionate—Spironolactone—PGR—polycystic ovary syndrome	0.000126	0.0135	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000126	0.0012	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—POMC—polycystic ovary syndrome	0.000125	0.00119	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000125	0.00119	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000124	0.00118	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000123	0.00117	CbGpPWpGaD
Testosterone Propionate—Danazol—SHBG—polycystic ovary syndrome	0.000123	0.0132	CrCbGaD
Testosterone Propionate—AR—Gene Expression—LSM5—polycystic ovary syndrome	0.000122	0.00117	CbGpPWpGaD
Testosterone Propionate—Hydrocortamate—NR3C1—polycystic ovary syndrome	0.000118	0.0128	CrCbGaD
Testosterone Propionate—Levonorgestrel—AR—polycystic ovary syndrome	0.000118	0.0127	CrCbGaD
Testosterone Propionate—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000118	0.0127	CrCbGaD
Testosterone Propionate—Spironolactone—SHBG—polycystic ovary syndrome	0.000117	0.0127	CrCbGaD
Testosterone Propionate—Norethindrone—PGR—polycystic ovary syndrome	0.000117	0.0126	CrCbGaD
Testosterone Propionate—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.000116	0.0126	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000115	0.00109	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000114	0.00108	CbGpPWpGaD
Testosterone Propionate—Fluoxymesterone—AR—polycystic ovary syndrome	0.000112	0.0121	CrCbGaD
Testosterone Propionate—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.000112	0.0121	CrCbGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000112	0.00107	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TEAD2—polycystic ovary syndrome	0.000111	0.00106	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKR1C2—polycystic ovary syndrome	0.000111	0.00106	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.00011	0.0119	CrCbGaD
Testosterone Propionate—Norethindrone—SHBG—polycystic ovary syndrome	0.000109	0.0118	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000109	0.00104	CbGpPWpGaD
Testosterone Propionate—Danazol—AR—polycystic ovary syndrome	0.000107	0.0116	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—TEAD2—polycystic ovary syndrome	0.000107	0.00102	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000107	0.00102	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000105	0.001	CbGpPWpGaD
Testosterone Propionate—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000104	0.0112	CrCbGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000104	0.000988	CbGpPWpGaD
Testosterone Propionate—Spironolactone—AR—polycystic ovary syndrome	0.000103	0.0111	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000103	0.000979	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000102	0.000969	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—CYP19A1—polycystic ovary syndrome	9.88e-05	0.0106	CrCbGaD
Testosterone Propionate—AR—Gene Expression—TEAD2—polycystic ovary syndrome	9.66e-05	0.000922	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	9.65e-05	0.0104	CrCbGaD
Testosterone Propionate—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	9.59e-05	0.000915	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PNPLA2—polycystic ovary syndrome	9.34e-05	0.000891	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NMNAT3—polycystic ovary syndrome	9.23e-05	0.000881	CbGpPWpGaD
Testosterone Propionate—Fludrocortisone—NR3C1—polycystic ovary syndrome	9.23e-05	0.00995	CrCbGaD
Testosterone Propionate—Progesterone—CYP17A1—polycystic ovary syndrome	9.17e-05	0.00988	CrCbGaD
Testosterone Propionate—Methyltestosterone—AR—polycystic ovary syndrome	9.08e-05	0.00979	CrCbGaD
Testosterone Propionate—Danazol—CYP19A1—polycystic ovary syndrome	8.99e-05	0.0097	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—PNPLA2—polycystic ovary syndrome	8.94e-05	0.000853	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SRD5A1—polycystic ovary syndrome	8.85e-05	0.000845	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP11A1—polycystic ovary syndrome	8.52e-05	0.00919	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—SRD5A1—polycystic ovary syndrome	8.48e-05	0.000809	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—LPCAT2—polycystic ovary syndrome	8.45e-05	0.000806	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SUOX—polycystic ovary syndrome	8.45e-05	0.000806	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—STAR—polycystic ovary syndrome	8.45e-05	0.000806	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	8.38e-05	0.000799	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	8.21e-05	0.000783	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—STAR—polycystic ovary syndrome	8.09e-05	0.000772	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.99e-05	0.000763	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ISYNA1—polycystic ovary syndrome	7.85e-05	0.000749	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—POMC—polycystic ovary syndrome	7.83e-05	0.000747	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—SHBG—polycystic ovary syndrome	7.8e-05	0.00841	CrCbGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	7.79e-05	0.000743	CbGpPWpGaD
Testosterone Propionate—Fluoxymesterone—NR3C1—polycystic ovary syndrome	7.63e-05	0.00822	CrCbGaD
Testosterone Propionate—Methyltestosterone—CYP19A1—polycystic ovary syndrome	7.6e-05	0.00819	CrCbGaD
Testosterone Propionate—COMT—Metabolism—HMMR—polycystic ovary syndrome	7.53e-05	0.000718	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HMMR—polycystic ovary syndrome	7.21e-05	0.000688	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HSD3B1—polycystic ovary syndrome	7.18e-05	0.000685	CbGpPWpGaD
Testosterone Propionate—Spironolactone—NR3C1—polycystic ovary syndrome	6.98e-05	0.00753	CrCbGaD
Testosterone Propionate—AR—Gene Expression—RPL37A—polycystic ovary syndrome	6.89e-05	0.000657	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HSD3B1—polycystic ovary syndrome	6.88e-05	0.000656	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	6.8e-05	0.000649	CbGpPWpGaD
Testosterone Propionate—Progesterone—PGR—polycystic ovary syndrome	6.8e-05	0.00733	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.8e-05	0.000649	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKR1C2—polycystic ovary syndrome	6.68e-05	0.000637	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TEAD2—polycystic ovary syndrome	6.68e-05	0.000637	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—LHB—polycystic ovary syndrome	6.55e-05	0.000625	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	6.54e-05	0.00705	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.44e-05	0.000615	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HSD3B2—polycystic ovary syndrome	6.4e-05	0.000611	CbGpPWpGaD
Testosterone Propionate—Progesterone—SHBG—polycystic ovary syndrome	6.35e-05	0.00685	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—LHB—polycystic ovary syndrome	6.27e-05	0.000598	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKR1C1—polycystic ovary syndrome	6.2e-05	0.000591	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	6.14e-05	0.000586	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HSD3B2—polycystic ovary syndrome	6.13e-05	0.000585	CbGpPWpGaD
Testosterone Propionate—Testosterone—SHBG—polycystic ovary syndrome	6.01e-05	0.00648	CrCbGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.98e-05	0.000571	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKR1C1—polycystic ovary syndrome	5.94e-05	0.000566	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SULT2A1—polycystic ovary syndrome	5.7e-05	0.000544	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.69e-05	0.000543	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PNPLA2—polycystic ovary syndrome	5.59e-05	0.000534	CbGpPWpGaD
Testosterone Propionate—Progesterone—AR—polycystic ovary syndrome	5.57e-05	0.00601	CrCbGaD
Testosterone Propionate—COMT—Metabolism—RRM2—polycystic ovary syndrome	5.52e-05	0.000527	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SULT2A1—polycystic ovary syndrome	5.46e-05	0.000521	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—YAP1—polycystic ovary syndrome	5.33e-05	0.000508	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SRD5A1—polycystic ovary syndrome	5.3e-05	0.000506	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—RRM2—polycystic ovary syndrome	5.29e-05	0.000505	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	5.27e-05	0.000503	CbGpPWpGaD
Testosterone Propionate—Testosterone—AR—polycystic ovary syndrome	5.27e-05	0.00568	CrCbGaD
Testosterone Propionate—COMT—Metabolism—NAMPT—polycystic ovary syndrome	5.12e-05	0.000488	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—YAP1—polycystic ovary syndrome	5.1e-05	0.000487	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.09e-05	0.000486	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—STAR—polycystic ovary syndrome	5.06e-05	0.000483	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP11A1—polycystic ovary syndrome	5.05e-05	0.000482	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NAMPT—polycystic ovary syndrome	4.9e-05	0.000467	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.87e-05	0.000465	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP11A1—polycystic ovary syndrome	4.84e-05	0.000462	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.8e-05	0.000458	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKR1C3—polycystic ovary syndrome	4.77e-05	0.000455	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP17A1—polycystic ovary syndrome	4.7e-05	0.000448	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—NR3C1—polycystic ovary syndrome	4.64e-05	0.005	CrCbGaD
Testosterone Propionate—AR—Gene Expression—YAP1—polycystic ovary syndrome	4.62e-05	0.000441	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKR1C3—polycystic ovary syndrome	4.57e-05	0.000436	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HMMR—polycystic ovary syndrome	4.51e-05	0.00043	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP19A1—polycystic ovary syndrome	4.41e-05	0.00475	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.3e-05	0.00041	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.14e-05	0.000395	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.08e-05	0.000389	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	4.07e-05	0.000389	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TH—polycystic ovary syndrome	4.06e-05	0.000388	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PGR—polycystic ovary syndrome	4.03e-05	0.000385	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC2A4—polycystic ovary syndrome	3.95e-05	0.000377	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—LHB—polycystic ovary syndrome	3.92e-05	0.000374	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TH—polycystic ovary syndrome	3.89e-05	0.000371	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.83e-05	0.000366	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.79e-05	0.000361	CbGpPWpGaD
Testosterone Propionate—Progesterone—NR3C1—polycystic ovary syndrome	3.78e-05	0.00407	CrCbGaD
Testosterone Propionate—COMT—Metabolism—CYP19A1—polycystic ovary syndrome	3.72e-05	0.000355	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.71e-05	0.000354	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.68e-05	0.000351	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP19A1—polycystic ovary syndrome	3.56e-05	0.00034	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1A1—polycystic ovary syndrome	3.43e-05	0.0037	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.42e-05	0.000326	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GNAS—polycystic ovary syndrome	3.32e-05	0.000317	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RRM2—polycystic ovary syndrome	3.31e-05	0.000316	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP1A1—polycystic ovary syndrome	3.24e-05	0.0035	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—YAP1—polycystic ovary syndrome	3.19e-05	0.000304	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GNAS—polycystic ovary syndrome	3.18e-05	0.000303	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NCOR1—polycystic ovary syndrome	3.16e-05	0.000302	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NAMPT—polycystic ovary syndrome	3.07e-05	0.000292	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NCOR1—polycystic ovary syndrome	3.03e-05	0.000289	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.03e-05	0.000289	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1A1—polycystic ovary syndrome	3e-05	0.000286	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.87e-05	0.000274	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.86e-05	0.000273	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.81e-05	0.000269	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTHFR—polycystic ovary syndrome	2.79e-05	0.000267	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NCOR1—polycystic ovary syndrome	2.74e-05	0.000262	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—polycystic ovary syndrome	2.68e-05	0.000255	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR3C1—polycystic ovary syndrome	2.54e-05	0.000242	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TH—polycystic ovary syndrome	2.44e-05	0.000232	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.37e-05	0.000226	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—polycystic ovary syndrome	2.27e-05	0.000216	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—POMC—polycystic ovary syndrome	2.23e-05	0.000213	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.23e-05	0.000212	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—INS—polycystic ovary syndrome	2.22e-05	0.000212	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—polycystic ovary syndrome	2.17e-05	0.000207	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—POMC—polycystic ovary syndrome	2.14e-05	0.000204	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—INS—polycystic ovary syndrome	2.13e-05	0.000203	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GNAS—polycystic ovary syndrome	1.99e-05	0.00019	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—polycystic ovary syndrome	1.96e-05	0.000187	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.89e-05	0.000181	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.8e-05	0.000171	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.77e-05	0.000169	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.67e-05	0.00016	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	1.36e-05	0.000129	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	1.34e-05	0.000128	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—INS—polycystic ovary syndrome	1.33e-05	0.000127	CbGpPWpGaD
